Iceland· IS-940012

Varilrix

A varicella, live attenuated product containing varicella-zoster virus, registered in Iceland by GlaxoSmithKline Pharma A/S. The same ATC class is registered in 11 of our 19 countries.

ATC J07BK01

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedVarilrixATCJ07BK01REGISTER NO.IS-940012PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Varicella, live attenuated is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BK01 (varicella, live attenuated), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 7 of them publish a price we can compare per daily dose

Varicella, live attenuated · ATC J07BK01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Varicella-Zoster Virus
Manufacturer
GlaxoSmithKline Pharma A/S
Country
Iceland (IS)
ATC code
J07BK01
ATC class
Varicella, live attenuated
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Varicella, live attenuated in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All varicella, live attenuated products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Germany · Varivax

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/52a65a79-19e4-4feb-9d88-a7affe8c676c
GET /v1/drugs/52a65a79-19e4-4feb-9d88-a7affe8c676c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stungulyfsstofn og leysir, lausn",
  "source": "lyfjastofnun",
  "atc_raw": "J07BK01",
  "marketed": true,
  "strength": null,
  "ma_number": "940012",
  "substance": "Varicella-Zoster Virus",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "34973"
}

See everything about varicella, live attenuated.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.